NAMPT and pulmonary arterial hypertension: Indeed, nicotinamide phosphoribosyltransferase (NAMPT), the enzyme responsible for NAD+ synthesis via the salvage pathway, was increased in the circulation and lung of advanced PAH patients, and NAMPT inhibition has shown therapeutic effects in rodent models of PH by reversing pulmonary vascular remodeling11.